Talk:PROM1

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of molecular biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology
???	This article has not yet received a rating on the project's importance scale.
	This article is supported by the Molecular and Cell Biology task force (assessed as Low-importance).

CD133 article improvement

Latest comment: 7 years ago1 comment1 person in discussion

Over the next few weeks I'll be working on improving and expanding the article for CD133. I've compiled an initial bibliography that I'll be using to develop content for this purpose. Let me know if you have any suggestions for references to add/remove to this list as well as specific topics that should be addressed in this project.

Thamm, Kristina; Šimaitė, Deimantė; Karbanová, Jana; Bermúdez, Vicente; Reichert, Doreen; Morgenstern, Anne; Bornhäuser, Martin; Huttner, Wieland B.; Wilsch-Bräuninger, Michaela (2018-10-17). "Prominin-1 (CD133) modulates the architecture and dynamics of microvilli". Traffic (Copenhagen, Denmark). doi:10.1111/tra.12618. ISSN 1600-0854. PMID 30328220.
Glumac, Paige M.; LeBeau, Aaron M. (2018-07-09). "The role of CD133 in cancer: a concise review". Clinical and Translational Medicine. 7 (1): 18. doi:10.1186/s40169-018-0198-1. ISSN 2001-1326. PMC 6035906. PMID 29984391.{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link)
Fan, Xing; Khaki, Leila; Zhu, Thant S.; Soules, Mary E.; Talsma, Caroline E.; Gul, Naheed; Koh, Cheryl; Zhang, Jiangyang; Li, Yue-Ming (2009). "Notch Pathway Blockade Depletes CD133-Positive Glioblastoma Cells and Inhibits Growth of Tumor Neurospheres and Xenografts". Stem Cells. 28 (1): N/A–N/A. doi:10.1002/stem.254. ISSN 1066-5099. PMC 2878196. PMID 19904829.{{cite journal}}: CS1 maint: PMC format (link)
Shmelkov, Sergey V.; Butler, Jason M.; Hooper, Andrea T.; Hormigo, Adilia; Kushner, Jared; Milde, Till; St. Clair, Ryan; Baljevic, Muhamed; White, Ian (2008-05-01). "CD133 expression is not restricted to stem cells, and both CD133+ and CD133– metastatic colon cancer cells initiate tumors". Journal of Clinical Investigation. 118 (6). doi:10.1172/JCI34401. ISSN 0021-9738.
Zeppernick, Felix; Ahmadi, Rezvan; Campos, Benito; Dictus, Christine; Helmke, Burkhard M.; Becker, Natalia; Lichter, Peter; Unterberg, Andreas; Radlwimmer, Bernhard (2008-01-01). "Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients". Clinical Cancer Research. 14 (1): 123–129. doi:10.1158/1078-0432.CCR-07-0932. ISSN 1078-0432. PMID 18172261.
Beier, Dagmar; Hau, Peter; Proescholdt, Martin; Lohmeier, Annette; Wischhusen, Jörg; Oefner, Peter J.; Aigner, Ludwig; Brawanski, Alexander; Bogdahn, Ulrich (2007-05-01). "CD133+ and CD133− Glioblastoma-Derived Cancer Stem Cells Show Differential Growth Characteristics and Molecular Profiles". Cancer Research. 67 (9): 4010–4015. doi:10.1158/0008-5472.CAN-06-4180. ISSN 0008-5472. PMID 17483311.
"Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential". European Journal of Cancer. 43 (5): 935–946. 2007-03-01. doi:10.1016/j.ejca.2007.01.017. ISSN 0959-8049.

Slargman (talk) 23:37, 25 October 2018 (UTC)Reply